One in four patients say they’ve skimped on insulin because of high cost

One in four patients say they’ve skimped on insulin because of high cost

This post was originally published on this site

For patients with diabetes, insulin is a life-saving medicine and an essential component of diabetes management, yet in the past decade alone, the out-of-pocket costs for insulin have doubled in the United States. One-quarter of patients with type 1 or 2 diabetes have reported using less insulin than prescribed due to these high costs, researchers say, and over a third of those patients experiencing cost-related underuse said they never discussed this reality with their provider.